Clinical Trials Logo

Deafness clinical trials

View clinical trials related to Deafness.

Filter by:

NCT ID: NCT02497690 Completed - Clinical trials for Congenital Sensorineural Deafness

Effectiveness of Therapy Via Telemedicine Following Cochlear Implants

TACIT
Start date: September 2013
Phase: Phase 2
Study type: Interventional

This study will assess the effectiveness of post-cochlear implant or hearing aid fitting Aural Rehabilitative Therapy (ART) delivered by means of telemedicine technology.

NCT ID: NCT02438618 Completed - Clinical trials for Conductive Hearing Loss

Minimally Invasive Surgery for Ponto Bone Anchored Hearing Implants

C50
Start date: December 2, 2014
Phase: N/A
Study type: Interventional

The objective of this study is to make a comparison between two surgical techniques used when implanting a Ponto bone anchored hearing system.

NCT ID: NCT02425397 Completed - Hearing Loss Clinical Trials

Cancer and Hearing Loss Related in Children

OTOPLAT
Start date: March 27, 2011
Phase:
Study type: Observational

A limited number of relatively contradictory studies have suggested that the development of serious ototoxicity in children treated with cisplatin or, more rarely, carboplatin could be partly related to genetic risk factors affecting detoxification enzymes and membrane transporters of platinum derivatives. The objective of this study is therefore to identify genetic variants associated with the development of platinum ototoxicity in patients treated with cisplatin or carboplatin (minimum follow-up of 3 years) for one of the following diseases: neuroblastoma, hepatoblastoma, retinoblastoma, malignant germ cell tumour, osteosarcoma, high-risk or recurrent Wilms' tumour, non-parameningealrhabdomyosarcoma. A total of 180 patients, corresponding to 60 cases with grade 3 or 4 ototoxicity and 120 controls with no signs of ototoxicity (separate complete audiograms for each ear) will be included. A saliva sample will be used to obtain DNA for pharmacogenetic studies. The value of this study will be to define a population at high risk of developing ototoxicity in order to adapt treatment, or even develop preventive treatment of ototoxicity based on antioxidant medications

NCT ID: NCT02423746 Completed - Hearing Loss Clinical Trials

Assessing and Addressing Behaviors in Children With Hearing Loss

Start date: April 2015
Phase: N/A
Study type: Interventional

Purpose: This study is a feasibility trial of an existing evidence-based behavioral parent training program with parents of preschool-aged children who were born deaf or hard of hearing (DHH). The hypotheses of this study are (a) that a randomized control trial of the Family Check Up with this population will be feasible, (b) parents will rate the intervention as acceptable, and (c) a signal of effect will be observable among intervention group parents compared to controls for the following outcome variables: child behaviors, parenting behaviors, and parenting sense of competence.

NCT ID: NCT02414152 Completed - Clinical trials for Hearing Loss, Sudden

Study of the Effects of Anakinra in Corticosteroid-resistant Subjects With Sudden Sensorineural Hearing Loss

SSNHL
Start date: October 2013
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to determine if anakinra (an interleukin-1 receptor antagonist) can improve hearing thresholds in patients with sudden sensorineural hearing loss that did not respond to oral steroid therapy. The patients to be enrolled will have recently completed a course of oral steroids and demonstrated no change in their audiometric thresholds following corticosteroid therapy. The investigators will be measuring hearing thresholds (Pure tone average and word recognition scores) before and after anakinra and correlating these findings with circulating IL-1 levels in the patient's blood.

NCT ID: NCT02381782 Completed - Cancer Clinical Trials

Validation of uHear™ as a Screening Tool to Detect Hearing Impairment in Elderly Cancer Patients Within a Comprehensive Geriatric Assessment

UHEAR
Start date: December 2014
Phase: N/A
Study type: Observational

Over the last few years, there has been a considerable interest in the development of screening tools to assess the capability of elderly cancer patients to tolerate anti-cancer treatment. Therefore, the NCCN Guidelines in Senior Adult Oncology recommend an assessment of co-morbid conditions that are likely to interfere with cancer treatment and tolerability. As presbyacusis is common in an older population, elderly cancer patients are at high risk for social isolation and a reduced quality of life. Therefore, in this project the investigators aim to validatie uHear™ as a quick and reliable screening tool to screen for presbyacusisf in routine clinical oncology practice.

NCT ID: NCT02369718 Completed - Hard of Hearing Clinical Trials

Cochlear Implants : Influence of Microphone Aging and Dirtying

Start date: November 2014
Phase: N/A
Study type: Interventional

Cochlear implant microphones are subject to aging and dirtying. The evolution may affect their efficiency. Several signal coding strategies are used in cochlear implants and their behaviour may be more or less affected by the aging process. In this work the investigators wish to assess this phenomenon.

NCT ID: NCT02345031 Completed - Clinical trials for Age-Related Hearing Loss

Efficacy and Safety of AUT00063 Versus Placebo in Age-Related Hearing Loss

CLARITY-1
Start date: January 2015
Phase: Phase 2
Study type: Interventional

This study aims to demonstrate that the investigational drug AUT00063 is effective and safe in the treatment of age-related hearing loss.

NCT ID: NCT02323256 Completed - Deafness Clinical Trials

Neurophysiological Measures of Auditory Perception and Rehabilitation in Cochlear Implanted Patients

NEUROSYLLABIC
Start date: July 2014
Phase: N/A
Study type: Interventional

This study aims at investigating new automatic fitting techniques for cochlear implant patients based on objective measures. For this reason, the evolution of these neurophysiological measures, expressing the encoding of pure tones and speech, will be characterized in cochlear implanted patients as a function of post-implantation time and will be compared to those of normal hearing subjects. Moreover, the effect of auditory training with new tools based on serious games will be assessed.

NCT ID: NCT02309541 Completed - Hearing Loss Clinical Trials

Evaluation of New Feedback Canceller for Carina™ Implant

Start date: February 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate audio quality benefit for the patient implanted with a Cochlear or Otologics Carina implant with the new firmware (feedback canceller algorithm) whatever the patient environment is and to evaluate the functional gain and speech understanding benefit for the patient upon the firmware used (new and reference firmware). The new firmware aims to adapt automatically for feedback cancellation without prior calibration.